{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:18:42Z","timestamp":1788344322812,"version":"build-2803163510"},"reference-count":68,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"crossref","award":["BX005613"],"award-info":[{"award-number":["BX005613"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["AT10980"],"award-info":[{"award-number":["AT10980"]}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"crossref","award":["1IK6 BX004982"],"award-info":[{"award-number":["1IK6 BX004982"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    It is important to describe new technologies for overcoming the barrier and promoting remyelination because many axons remain demyelinated in the CNS of multiple sclerosis (MS) patients. Recent studies indicate that TLR2 is a negative regulator of maturation of oligodendroglial progenitor cells (OPCs) to oligodendrocytes (OLs) and that TLR2 is present in human MS chronic lesions. However, until recently, there was no specific inhibitor of TLR2. Therefore, we have engineered a peptide corresponding to the TLR2-interacting domain of MyD88 (TIDM) that specifically inhibits TLR2, but not other TLRs. This study underscores the importance of wild type TIDM (wtTIDM) peptide in promoting the maturation of OPCs to oligodendrocytes. The expression of different maturation markers including PLP, MBP and MOG increased in cultured OPCs in response to wtTIDM, but not mTIDM. While investigating mechanisms, we found that wtTIDM peptide increased the maturation of OPCs isolated from TLR4\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice, but not TLR2\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice, indicating that wtTIDM requires the association with TLR2, but not TLR4, to exhibit this new function. Finally, as evident from double label immunohistochemistry and Western blotting, intranasal administration of wtTIDM, but not mTIDM, was capable of increasing OPC maturation and promoting remyelination in the corpus callosum of cuprizone-intoxicated mouse model of demyelination. These results indicate that wtTIDM stimulates the maturation of OPCs via TLR2 and that intranasal wtTIDM may be further evaluated preclinically for stimulating remyelination.\n                  <\/jats:p>","DOI":"10.1515\/nipt-2026-0021","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:57:32Z","timestamp":1788343052000},"source":"Crossref","is-referenced-by-count":0,"title":["Selective inhibition of\u00a0TLR2 stimulates the\u00a0maturation of\u00a0oligodendroglial progenitor cells to\u00a0oligodendrocytes"],"prefix":"10.1515","author":[{"given":"Sudipta","family":"Chakrabarti","sequence":"first","affiliation":[{"name":"Division of Research and Development , Jesse Brown Veterans Affairs Medical Center , Chicago , IL , USA"},{"name":"Department of Neurological Sciences , Rush University Medical Center , Chicago , IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malabendu","family":"Jana","sequence":"additional","affiliation":[{"name":"Division of Research and Development , Jesse Brown Veterans Affairs Medical Center , Chicago , IL , USA"},{"name":"Department of Neurological Sciences , Rush University Medical Center , Chicago , IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhamoy","family":"Gorai","sequence":"additional","affiliation":[{"name":"Division of Research and Development , Jesse Brown Veterans Affairs Medical Center , Chicago , IL , USA"},{"name":"Department of Neurological Sciences , Rush University Medical Center , Chicago , IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalipada","family":"Pahan","sequence":"additional","affiliation":[{"name":"Division of Research and Development , Jesse Brown Veterans Affairs Medical Center , Chicago , IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"2026090209572822940_j_nipt-2026-0021_ref_001","doi-asserted-by":"crossref","unstructured":"Dendrou, CA, Fugger, L, Friese, MA. Immunopathology of multiple sclerosis. Nat Rev Immunol 2015;15:545\u201358. https:\/\/doi.org\/10.1038\/nri3871.","DOI":"10.1038\/nri3871"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_002","doi-asserted-by":"crossref","unstructured":"Pahan, K. Multiple sclerosis and experimental allergic encephalomyelitis. J Clin Cell Immunol 2013;4.","DOI":"10.4172\/2155-9899.1000e113"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_003","doi-asserted-by":"crossref","unstructured":"Bose, A, Pahan, K. Build muscles and protect myelin. NeuroImmune Pharm Ther 2024;3:175\u201382. https:\/\/doi.org\/10.1515\/nipt-2024-0015.","DOI":"10.1515\/nipt-2024-0015"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_004","doi-asserted-by":"crossref","unstructured":"Hartline, DK. What is myelin? Neuron Glia Biol 2008;4:153\u201363. https:\/\/doi.org\/10.1017\/s1740925x09990263.","DOI":"10.1017\/S1740925X09990263"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_005","doi-asserted-by":"crossref","unstructured":"Gonzalez-Perez, O, Alvarez-Buylla, A. Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor. Brain Res Rev 2011;67:147\u201356. https:\/\/doi.org\/10.1016\/j.brainresrev.2011.01.001.","DOI":"10.1016\/j.brainresrev.2011.01.001"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_006","doi-asserted-by":"crossref","unstructured":"Jana, M, Prieto, S, Gorai, S, Dasarathy, S, Kundu, M, Pahan, K. Muscle-building supplement beta-hydroxy beta-methylbutyrate stimulates the maturation of oligodendroglial progenitor cells to oligodendrocytes. J Neurochem 2024;168:1340\u201358. https:\/\/doi.org\/10.1111\/jnc.16084.","DOI":"10.1111\/jnc.16084"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_007","doi-asserted-by":"crossref","unstructured":"Akira, S, Takeda, K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499\u2013511. https:\/\/doi.org\/10.1038\/nri1391.","DOI":"10.1038\/nri1391"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_008","doi-asserted-by":"crossref","unstructured":"Dutta, D, Jana, M, Majumder, M, Mondal, S, Roy, A, Pahan, K. Selective targeting of the TLR2\/MyD88\/NF-kappaB pathway reduces alpha-synuclein spreading in vitro and in vivo. Nat Commun 2021;12:5382. https:\/\/doi.org\/10.1038\/s41467-021-25767-1.","DOI":"10.1038\/s41467-021-25767-1"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_009","doi-asserted-by":"crossref","unstructured":"Rangasamy, SB, Jana, M, Roy, A, Corbett, GT, Kundu, M, Chandra, S, et al.. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer\u2019s pathology. J Clin Investig 2018;128:4297\u2013312. https:\/\/doi.org\/10.1172\/jci96209.","DOI":"10.1172\/JCI96209"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_010","doi-asserted-by":"crossref","unstructured":"Nouri, Y, Weinkove, R, Perret, R. T-cell intrinsic toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells. J Immunother Cancer 2021;9. https:\/\/doi.org\/10.1136\/jitc-2021-003065.","DOI":"10.1136\/jitc-2021-003065"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_011","doi-asserted-by":"crossref","unstructured":"Rouillard, ME, Hu, J, Sutter, PA, Kim, HW, Huang, JK, Crocker, SJ. The cellular senescence factor extracellular HMGB1 directly inhibits oligodendrocyte progenitor cell differentiation and impairs CNS remyelination. Front Cell Neurosci 2022;16:833186. https:\/\/doi.org\/10.3389\/fncel.2022.833186.","DOI":"10.3389\/fncel.2022.833186"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_012","doi-asserted-by":"crossref","unstructured":"Sloane, JA, Batt, C, Ma, Y, Harris, ZM, Trapp, B, Vartanian, T. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc Natl Acad Sci USA 2010;107:11555\u201360. https:\/\/doi.org\/10.1073\/pnas.1006496107.","DOI":"10.1073\/pnas.1006496107"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_013","doi-asserted-by":"crossref","unstructured":"Dutta, D, Jana, M, Paidi, RK, Majumder, M, Raha, S, Dasarathy, S, et al.. Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer\u2019s disease-related mouse models. J Clin Investig 2023;133. https:\/\/doi.org\/10.1172\/jci161987.","DOI":"10.1172\/JCI161987"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_014","doi-asserted-by":"crossref","unstructured":"Jana, M, Jana, A, Pal, U, Pahan, K. A simplified method for isolating highly purified neurons, oligodendrocytes, astrocytes, and microglia from the same human fetal brain tissue. Neurochem Res 2007;32:2015\u201322. https:\/\/doi.org\/10.1007\/s11064-007-9340-y.","DOI":"10.1007\/s11064-007-9340-y"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_015","doi-asserted-by":"crossref","unstructured":"Jana, M, Mondal, S, Gonzalez, FJ, Pahan, K. Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-beta. J Biol Chem 2012;287:34134\u201348. https:\/\/doi.org\/10.1074\/jbc.m112.398552.","DOI":"10.1074\/jbc.M112.398552"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_016","doi-asserted-by":"crossref","unstructured":"Dincman, TA, Beare, JE, Ohri, SS, Whittemore, SR. Isolation of cortical mouse oligodendrocyte precursor cells. J Neurosci Methods 2012;209:219\u201326. https:\/\/doi.org\/10.1016\/j.jneumeth.2012.06.017.","DOI":"10.1016\/j.jneumeth.2012.06.017"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_017","doi-asserted-by":"crossref","unstructured":"Dutta, D, Paidi, RK, Raha, S, Roy, A, Chandra, S, Pahan, K. Treadmill exercise reduces alpha-synuclein spreading via PPARalpha. Cell Rep 2022;40:111058. https:\/\/doi.org\/10.1016\/j.celrep.2022.111058.","DOI":"10.1016\/j.celrep.2022.111058"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_018","doi-asserted-by":"crossref","unstructured":"Jana, M, Dutta, D, Poddar, J, Pahan, K. Activation of PPARalpha exhibits therapeutic efficacy in a mouse model of juvenile neuronal ceroid lipofuscinosis. J Neurosci 2023;43:1814\u201329. https:\/\/doi.org\/10.1523\/jneurosci.2447-21.2023.","DOI":"10.1523\/JNEUROSCI.2447-21.2023"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_019","doi-asserted-by":"crossref","unstructured":"Khasnavis, S, Ghosh, A, Roy, A, Pahan, K. Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase. J Biol Chem 2013;288:20843\u201355. https:\/\/doi.org\/10.1074\/jbc.m112.443556.","DOI":"10.1074\/jbc.M112.443556"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_020","doi-asserted-by":"crossref","unstructured":"Saha, RN, Ghosh, A, Palencia, CA, Fung, YK, Dudek, SM, Pahan, K. TNF-alpha preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein. J Immunol 2009;183:2068\u201378. https:\/\/doi.org\/10.4049\/jimmunol.0801892.","DOI":"10.4049\/jimmunol.0801892"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_021","doi-asserted-by":"crossref","unstructured":"Chakrabarti, S, Gorai, S, Pahan, K. A simple protocol for isolating microglia from adult mouse brain. NeuroImmune Pharm Ther 2023;2:293\u2013300. https:\/\/doi.org\/10.1515\/nipt-2023-0014.","DOI":"10.1515\/nipt-2023-0014"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_022","doi-asserted-by":"crossref","unstructured":"Gottschalk, CG, Jana, M, Roy, A, Patel, DR, Pahan, K. Gemfibrozil protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease via PPARalpha-dependent astrocytic GDNF pathway. J Neurosci 2021;41:2287\u2013300. https:\/\/doi.org\/10.1523\/jneurosci.3018-19.2021.","DOI":"10.1523\/JNEUROSCI.3018-19.2021"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_023","doi-asserted-by":"crossref","unstructured":"Raha, S, Ghosh, A, Dutta, D, Patel, DR, Pahan, K. Activation of PPARalpha enhances astroglial uptake and degradation of beta-amyloid. Sci Signal 2021;14:eabg4747. https:\/\/doi.org\/10.1126\/scisignal.abg4747.","DOI":"10.1126\/scisignal.abg4747"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_024","doi-asserted-by":"crossref","unstructured":"Paidi, RK, Raha, S, Roy, A, Pahan, K. Muscle-building supplement beta-hydroxy beta-methylbutyrate binds to PPARalpha to improve hippocampal functions in mice. Cell Rep 2023;42:112717. https:\/\/doi.org\/10.1016\/j.celrep.2023.112717.","DOI":"10.1016\/j.celrep.2023.112717"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_025","doi-asserted-by":"crossref","unstructured":"Raha, S, Paidi, RK, Dutta, D, Pahan, K. Cinnamic acid, a natural plant compound, exhibits neuroprotection in a mouse model of sandhoff disease via PPARalpha. NeuroImmune Pharm Ther 2024;3:17\u201332. https:\/\/doi.org\/10.1515\/nipt-2023-0027.","DOI":"10.1515\/nipt-2023-0027"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_026","doi-asserted-by":"crossref","unstructured":"Chandra, G, Roy, A, Rangasamy, SB, Pahan, K. Induction of adaptive immunity leads to nigrostriatal disease progression in MPTP mouse model of Parkinson\u2019s disease. J Immunol 2017;198:4312\u201326. https:\/\/doi.org\/10.4049\/jimmunol.1700149.","DOI":"10.4049\/jimmunol.1700149"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_027","doi-asserted-by":"crossref","unstructured":"Kundu, M, Raha, S, Roy, A, Pahan, K. Regression of triple-negative breast cancer in a patient-derived xenograft mouse model by monoclonal antibodies against IL-12 p40 monomer. Cells 2022;11. https:\/\/doi.org\/10.3390\/cells11020259.","DOI":"10.3390\/cells11020259"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_028","doi-asserted-by":"crossref","unstructured":"Roy, A, Jana, M, Kundu, M, Corbett, GT, Rangaswamy, SB, Mishra, RK, et al.. HMG-CoA reductase inhibitors bind to PPARalpha to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab 2015;22:253\u201365. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.022.","DOI":"10.1016\/j.cmet.2015.05.022"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_029","doi-asserted-by":"crossref","unstructured":"Corbett, GT, Gonzalez, FJ, Pahan, K. Activation of peroxisome proliferator-activated receptor alpha stimulates ADAM10-mediated proteolysis of APP. Proc Natl Acad Sci USA 2015;112:8445\u201350. https:\/\/doi.org\/10.1073\/pnas.1504890112.","DOI":"10.1073\/pnas.1504890112"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_030","doi-asserted-by":"crossref","unstructured":"Rangasamy, SB, Corbett, GT, Roy, A, Modi, KK, Bennett, DA, Mufson, EJ, et al.. Intranasal delivery of NEMO-binding domain peptide prevents memory loss in a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 2015;47:385\u2013402. https:\/\/doi.org\/10.3233\/jad-150040.","DOI":"10.3233\/JAD-150040"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_031","doi-asserted-by":"crossref","unstructured":"Figarella-Branger, D, Colin, C, Baeza-Kallee, N, Tchoghandjian, A. A2B5 expression in central nervous system and gliomas. Int J Mol Sci 2022;23. https:\/\/doi.org\/10.3390\/ijms23094670.","DOI":"10.3390\/ijms23094670"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_032","doi-asserted-by":"crossref","unstructured":"Ravichandar, R, Gadelkarim, F, Muthaiah, R, Glynos, N, Murlanova, K, Rai, NK, et al.. Dysregulated cholinergic signaling inhibits oligodendrocyte maturation following demyelination. J Neurosci 2024;44. https:\/\/doi.org\/10.1523\/jneurosci.0051-24.2024.","DOI":"10.1523\/JNEUROSCI.0051-24.2024"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_033","doi-asserted-by":"crossref","unstructured":"Smith, T. The capsules or sheaths of bacillus actinoides. J Exp Med 1921;34:593\u20138. https:\/\/doi.org\/10.1084\/jem.34.6.593.","DOI":"10.1084\/jem.34.6.593"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_034","doi-asserted-by":"crossref","unstructured":"Sanders, FK, Whitteridge, D. Conduction velocity and myelin thickness in regenerating nerve fibres. J Physiol 1946;105:152\u201374. https:\/\/doi.org\/10.1113\/jphysiol.1946.sp004160.","DOI":"10.1113\/jphysiol.1946.sp004160"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_035","doi-asserted-by":"crossref","unstructured":"Friese, MA, Schattling, B, Fugger, L. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 2014;10:225\u201338. https:\/\/doi.org\/10.1038\/nrneurol.2014.37.","DOI":"10.1038\/nrneurol.2014.37"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_036","doi-asserted-by":"crossref","unstructured":"Jarius, S, Wildemann, B. The history of neuromyelitis optica. J Neuroinflammation 2019;10:8. https:\/\/doi.org\/10.1186\/1742-2094-10-8.","DOI":"10.1186\/1742-2094-10-8"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_037","doi-asserted-by":"crossref","unstructured":"Richardson, EPJr. Progressive multifocal leukoencephalopathy. N Engl J Med 1961;265:815\u201323. https:\/\/doi.org\/10.1056\/nejm196110262651701.","DOI":"10.1056\/NEJM196110262651701"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_038","doi-asserted-by":"crossref","unstructured":"Kondo, Y, Adams, JM, Vanier, MT, Duncan, ID. Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy. J Neurosci 2011;31:3610\u201324. https:\/\/doi.org\/10.1523\/jneurosci.6344-10.2011.","DOI":"10.1523\/JNEUROSCI.6344-10.2011"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_039","doi-asserted-by":"crossref","unstructured":"Zhang, W, Han, Y, Huang, H, Su, Y, Ren, H, Qi, C, et al.. CD22 blockade exacerbates neuroinflammation in neuromyelitis optica spectrum disorder. J Neuroinflammation 2024;21:313. https:\/\/doi.org\/10.1186\/s12974-024-03305-2.","DOI":"10.1186\/s12974-024-03305-2"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_040","doi-asserted-by":"crossref","unstructured":"Zhu, J, Eichler, F, Biffi, A, Duncan, CN, Williams, DA, Majzoub, JA. The changing face of adrenoleukodystrophy. Endocr Rev 2020;41:577\u201393. https:\/\/doi.org\/10.1210\/endrev\/bnaa013.","DOI":"10.1210\/endrev\/bnaa013"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_041","doi-asserted-by":"crossref","unstructured":"Pahan, K, Khan, M, Singh, I. Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP. J Lipid Res 1998;39:1091\u2013100. https:\/\/doi.org\/10.1016\/s0022-2275(20)33878-5.","DOI":"10.1016\/S0022-2275(20)33878-5"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_042","doi-asserted-by":"crossref","unstructured":"Akassoglou, K, Bauer, J, Kassiotis, G, Pasparakis, M, Lassmann, H, Kollias, G, et al.. Oligodendrocyte apoptosis and primary demyelination induced by local TNF\/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 1998;153:801\u201313. https:\/\/doi.org\/10.1016\/s0002-9440(10)65622-2.","DOI":"10.1016\/S0002-9440(10)65622-2"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_043","doi-asserted-by":"crossref","unstructured":"Traka, M, Podojil, JR, McCarthy, DP, Miller, SD, Popko, B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci 2016;19:65\u201374. https:\/\/doi.org\/10.1038\/nn.4193.","DOI":"10.1038\/nn.4193"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_044","doi-asserted-by":"crossref","unstructured":"Caprariello, AV, Mangla, S, Miller, RH, Selkirk, SM. Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. Ann Neurol 2012;72:395\u2013405. https:\/\/doi.org\/10.1002\/ana.23606.","DOI":"10.1002\/ana.23606"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_045","doi-asserted-by":"crossref","unstructured":"Jana, A, Hogan, EL, Pahan, K. Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death. J Neurol Sci 2009;278:5\u201315. https:\/\/doi.org\/10.1016\/j.jns.2008.12.010.","DOI":"10.1016\/j.jns.2008.12.010"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_046","doi-asserted-by":"crossref","unstructured":"Singh, I, Pahan, K, Khan, M, Singh, AK. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 1998;273:20354\u201362. https:\/\/doi.org\/10.1074\/jbc.273.32.20354.","DOI":"10.1074\/jbc.273.32.20354"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_047","doi-asserted-by":"crossref","unstructured":"Jana, M, Pahan, K. Down-regulation of myelin gene expression in human oligodendrocytes by nitric oxide: implications for demyelination in multiple sclerosis. J Clin Cell Immunol 2013;4. https:\/\/doi.org\/10.4172\/2155-9899.1000157.","DOI":"10.4172\/2155-9899.1000157"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_048","doi-asserted-by":"crossref","unstructured":"Beiter, RM, Rivet-Noor, C, Merchak, AR, Bai, R, Johanson, DM, Slogar, E, et al.. Evidence for oligodendrocyte progenitor cell heterogeneity in the adult mouse brain. Sci Rep 2022;12:12921. https:\/\/doi.org\/10.1038\/s41598-022-17081-7.","DOI":"10.1038\/s41598-022-17081-7"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_049","doi-asserted-by":"crossref","unstructured":"Elbaz, B, Popko, B. Molecular control of oligodendrocyte development. Trends Neurosci 2019;42:263\u201377. https:\/\/doi.org\/10.1016\/j.tins.2019.01.002.","DOI":"10.1016\/j.tins.2019.01.002"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_050","doi-asserted-by":"crossref","unstructured":"Kremer, D, Aktas, O, Hartung, HP, Kury, P. The complex world of oligodendroglial differentiation inhibitors. Ann Neurol 2011;69:602\u201318. https:\/\/doi.org\/10.1002\/ana.22415.","DOI":"10.1002\/ana.22415"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_051","doi-asserted-by":"crossref","unstructured":"Kremer, D, Kury, P, Dutta, R. Promoting remyelination in multiple sclerosis: current drugs and future prospects. Mult Scler 2015;21:541\u20139. https:\/\/doi.org\/10.1177\/1352458514566419.","DOI":"10.1177\/1352458514566419"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_052","doi-asserted-by":"crossref","unstructured":"Chong, SY, Chan, JR. Tapping into the glial reservoir: cells committed to remaining uncommitted. J Cell Biol 2010;188:305\u201312. https:\/\/doi.org\/10.1083\/jcb.200905111.","DOI":"10.1083\/jcb.200905111"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_053","doi-asserted-by":"crossref","unstructured":"Boyd, A, Zhang, H, Williams, A. Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 2013;125:841\u201359. https:\/\/doi.org\/10.1007\/s00401-013-1112-y.","DOI":"10.1007\/s00401-013-1112-y"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_054","doi-asserted-by":"crossref","unstructured":"Chang, A, Tourtellotte, WW, Rudick, R, Trapp, BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002;346:165\u201373. https:\/\/doi.org\/10.1056\/nejmoa010994.","DOI":"10.1056\/NEJMoa010994"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_055","doi-asserted-by":"crossref","unstructured":"Kuhlmann, T, Miron, V, Cui, Q, Wegner, C, Antel, J, Bruck, W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008;131:1749\u201358. https:\/\/doi.org\/10.1093\/brain\/awn096.","DOI":"10.1093\/brain\/awn096"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_056","doi-asserted-by":"crossref","unstructured":"Jana, M, Palencia, CA, Pahan, K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer\u2019s disease. J Immunol 2008;181:7254\u201362. https:\/\/doi.org\/10.4049\/jimmunol.181.10.7254.","DOI":"10.4049\/jimmunol.181.10.7254"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_057","doi-asserted-by":"crossref","unstructured":"Attfield, KE, Jensen, LT, Kaufmann, M, Friese, MA, Fugger, L. The immunology of multiple sclerosis. Nat Rev Immunol 2022;22:734\u201350. https:\/\/doi.org\/10.1038\/s41577-022-00718-z.","DOI":"10.1038\/s41577-022-00718-z"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_058","doi-asserted-by":"crossref","unstructured":"Becher, B, Derfuss, T, Liblau, R. Targeting cytokine networks in neuroinflammatory diseases. Nat Rev Drug Discov 2024;23:862\u201379. https:\/\/doi.org\/10.1038\/s41573-024-01026-y.","DOI":"10.1038\/s41573-024-01026-y"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_059","doi-asserted-by":"crossref","unstructured":"Saha, RN, Pahan, K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signaling 2006;8:929\u201347. https:\/\/doi.org\/10.1089\/ars.2006.8.929.","DOI":"10.1089\/ars.2006.8.929"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_060","doi-asserted-by":"crossref","unstructured":"Saha, RN, Pahan, K. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem Int 2006;49:154\u201363. https:\/\/doi.org\/10.1016\/j.neuint.2006.04.007.","DOI":"10.1016\/j.neuint.2006.04.007"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_061","doi-asserted-by":"crossref","unstructured":"Klotz, L, Antel, J, Kuhlmann, T. Inflammation in multiple sclerosis: consequences for remyelination and disease progression. Nat Rev Neurol 2023;19:305\u201320. https:\/\/doi.org\/10.1038\/s41582-023-00801-6.","DOI":"10.1038\/s41582-023-00801-6"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_062","doi-asserted-by":"crossref","unstructured":"Bittner, S, Pape, K, Klotz, L, Zipp, F. Implications of immunometabolism for smouldering MS pathology and therapy. Nat Rev Neurol 2023;19:477\u201388. https:\/\/doi.org\/10.1038\/s41582-023-00839-6.","DOI":"10.1038\/s41582-023-00839-6"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_063","doi-asserted-by":"crossref","unstructured":"Dasgupta, S, Jana, M, Zhou, Y, Fung, YK, Ghosh, S, Pahan, K. Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis. J Immunol 2004;173:1344\u201354. https:\/\/doi.org\/10.4049\/jimmunol.173.2.1344.","DOI":"10.4049\/jimmunol.173.2.1344"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_064","doi-asserted-by":"crossref","unstructured":"Dong, Y, Yong, VW. When encephalitogenic T cells collaborate with microglia in multiple sclerosis. Nat Rev Neurol 2019;15:704\u201317. https:\/\/doi.org\/10.1038\/s41582-019-0253-6.","DOI":"10.1038\/s41582-019-0253-6"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_065","doi-asserted-by":"crossref","unstructured":"Friis, LM, Keelan, M, Taylor, DE. Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via toll-like receptor 2. Infect Immun 2009;77:1553\u201360. https:\/\/doi.org\/10.1128\/iai.00707-08.","DOI":"10.1128\/IAI.00707-08"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_066","doi-asserted-by":"crossref","unstructured":"Gao, Q, Qi, L, Wu, T, Wang, J. Clostridium butyricum activates TLR2-mediated MyD88-independent signaling pathway in HT-29 cells. Mol Cell Biochem 2012;361:31\u20137. https:\/\/doi.org\/10.1007\/s11010-011-1084-y.","DOI":"10.1007\/s11010-011-1084-y"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_067","doi-asserted-by":"crossref","unstructured":"Poon, MM, Lorrain, KI, Stebbins, KJ, Edu, GC, Broadhead, AR, Lorenzana, AJ, et al.. Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. Proc Natl Acad Sci USA 2024;121:e2407974121. https:\/\/doi.org\/10.1073\/pnas.2407974121.","DOI":"10.1073\/pnas.2407974121"},{"key":"2026090209572822940_j_nipt-2026-0021_ref_068","doi-asserted-by":"crossref","unstructured":"Biname, F, Leguay, K, Spenle, C, Van Der Heyden, M, Kent, OA, Mancini, J, et al.. Disruption of Plexin-A1 signaling by FTX-101: mode of action and effect on oligodendrocyte biology. Biomed Pharmacother 2025;188:118186. https:\/\/doi.org\/10.1016\/j.biopha.2025.118186.","DOI":"10.1016\/j.biopha.2025.118186"}],"container-title":["NeuroImmune Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2026-0021\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2026-0021\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:57:38Z","timestamp":1788343058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2026-0021\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":68,"alternative-id":["10.1515\/nipt-2026-0021"],"URL":"https:\/\/doi.org\/10.1515\/nipt-2026-0021","relation":{},"ISSN":["2750-6665"],"issn-type":[{"value":"2750-6665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}